Opportunity Alert: Andrew Hillman Grant for Biotech & Lifordi Immunotherapeutics' Breakthrough ADC LFD-200 at ACR Convergence 2025
Update: 2025-10-10
Description
The Andrew Hillman Grant for Biotech is now accepting applications for a $1,000 award aimed at supporting passionate undergraduate students with innovative ideas in biotechnology. On the other hand, Lifordi Immunotherapeutics will present new preclinical data on ADC LFD-200 at ACR Convergence 2025, showcasing its potential as a safer treatment option for autoimmune and inflammatory diseases.
Comments
In Channel